• Exchange: Copenhagen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

H Lundbeck A/S

+ Add to Watchlist


159.2000 DKK 0.4000 0.25%

As of 11:02:19 ET on 04/24/2014.

Snapshot for H Lundbeck A/S (LUN)

Open: 159.8000 Day's Range: 158.5000 - 161.8000 Volume: 129,156
Previous Close: 159.6000 52wk Range: 97.5500 - 173.6000 1-Yr Rtn: +43.46%

Stock Chart for LUN

No chart data available.
  • LUN:DC 159.2000
  • 1D
  • 1M
  • 1Y
Interactive LUN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LUN

Current P/E Ratio (ttm) 36.5199
Estimated P/E(12/2014) 45.2659
Relative P/E vs. KFX 1.6219
Earnings Per Share (DKK) (ttm) 4.3593
Est. EPS (DKK) (12/2014) 3.5170
Est. PEG Ratio -
Market Cap (M DKK) 31,245.07
Shares Outstanding (M) 196.26
30 Day Average Volume 265,201
Price/Book (mrq) 2.3169
Price/Sale (ttm) 2.0466
Dividend Indicated Gross Yield 1.74%
Cash Dividend (DKK) 2.7700
Dividend Ex-Date 03/27/2014
5 Year Dividend Growth 3.79%
Next Earnings Announcement 05/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LUN

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for LUN

H. Lundbeck A/S is an international pharmaceutical company. The Company researches, manufactures, and sells drugs for the treatment of psychiatric and neurological disorders. The Company focuses on mood disorders, dementia, anxiety, and sleep disorders. Lundbeck does research both in-house and in cooperation with research centers. The Company markets its products worldwide.

Thorleif KrarupDeputy ChairmanUlf WiinbergPresident/CEO
Anders GotzscheExec VP/CFOAnders Gersel PedersenExec VP:Research & Dev
More Company Profile & Key Executives for LUN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil